The major metabolite from the use of furazolidone (FZD) in mammals, birds and fish is 2,3-dihydro-3-cyanomethyl-2-hydroxy-5-nitro-1alpha, 2-di(2-oxo-oxazolidin-3-yl)iminomethyl-furo [2,3-b]furan, also called 3-amine-2-oxazolidone (AOZ). A minor metabolite was identified as N-(5-amine-2-furfuryliden)-3-amine-2-oxazolidone (FOZ). To assess the potential carcinogenicity of FZD and the metabolic mixture of AOZ/FOZ, 11 mg FZD/ kg feed/day was fed for 12 weeks to mollies (Poecilia formosa), an ornamental fish species prone to develop tumors. The rate of tumors was quantified and defined both in mollies and their offspring. Then, some fish was made into fishmeal and incorporated into fish food at 500 g of meal/kg of food and fed to other mollies for 12 weeks. The rate of tumors was assessed. A similar trial design was carried out in tilapia fish (Oreochromis niloticus) by adding 50 mg FZD/kg to the feed for 90 days. All animals were placed in glass fishponds under controlled laboratory conditions. Each week, a significant biomass was collected from both groups to assess the macroscopic and histopathological changes. All mollies developed melanohistiocytomic tumors in the liver and other organs. Offspring from surviving mollie females stimulated to breed showed no changes compared to control animals. None of the mollies fed with the mollie-meal food contaminated with AOZ/FOZ developed tumors. Neither tilapia medicated with FZD nor tilapia fed with tilapia-meal contaminated with AOZ/FOZ developed tumors. These results do not support the established viewpoint that FZD must be banned from trophic chains based on its potential carcinogenic properties.
INTRODUCTION
Nitrofurans are a group of potent broad-spectrum antibacterial drugs also possessing antiprotozoal activity. They are still used to treat many bacterial and protozoal infections in food-producing animals worldwide, particularly in pigs and poultry, and are capable of inducing cancer, as well as having other toxic side effects under various experimental model designs. [1] [2] [3] Such evidence has been taken as the basis to prohibit their use in animal health in many countries.
Towards the end of the 80s, based on the idea of preventing a carcinogenic substance from reaching human consumers as per the Delaney Amendment, the US Food and Drug Administration banned the use of furazolidone (FZD) and nitrofurazone (later extended to furaltadone) for the treatment of diseases in food-producing animals. However, from a US-foreign perspective, it is feasible to question this prohibition. Cancer induction was established in laboratory animals directly receiving large quantities of a given nitrofuran; 1,2,4 but humans are not in the danger of consuming the nitrofuran agent from animal food sources, but rather residues of the main metabolites: 2,3-dihydro-3-cyanomethyl-2-hydroxy-5-nitro-1alpha,2-di(2-oxo-oxazolidin-3-yl)iminomethyl-furo 2,3-b furan, also called 3-amine-2-oxazolidone (AOZ), and a minor metabolite, N-(5-amino-2-furfuryliden)-3-amino-2-oxazolidone (FOZ). 5, 6 To date, evidence that AOZ/FOZ can induce genotoxic or carcinogenic changes is nonconclusive.
As in the case of mammals, fish metabolize FZD into AOZ and FOZ via cytocrome P-450; hence they can be used to study the carcinogenic effects that both FZD and its metabolites AOZ/FOZ may produce. 7 An ornamental gynogenetic fish species, Poecilia formosa (mollies) whose progenitors and descendants are genetically identical, is known to be prone to develop tumors, in part due to their peculiar breeding process. 8 This species has been regarded as a suitable model to test the carcinogenic potential of drugs, [9] [10] [11] [12] [13] [14] [15] and may be utilized to study the direct carcinogenic effects of FZD, as well as the indirect effects of AOZ. Also, a comparison of such effects was made in tilapia (Oreochromis niloticus).
MATERIAL AND METHODS

Mollies (Poecilia formosa)
In all, 1350 mollies, each 2 cm long and weighing approximately 1.2 g, were used. Fish were allocated in 40 l glass fishponds with a water turnover of 50% per week. A volume of 1 l air/min was pumped (Wave Pumps, W Lim Corporation, El Monte, CA, USA) in each, to maintain a water oxygen concentration of 5 ppm. A water temperature of 231C was ensured with a thermostat. Water variables (oxygen, temperature and pH) were measured daily (Digital Oximeter and Thermometer Pinpoint, American Marine Inc., Ridgefield, CT, Cherstertown, MA, USA). Ammonium, nitrites, water hardness and phosphate contents were measured by means of an automated system (Aqua LaMotte, Cherstertown, MA, USA).
In group Am, three replicates of 100 mollies were medicated with 11 mg of FZD/kg of feed/day for 12 weeks. Each week, seven mollies per replicate were demedulated and maintained in 10% buffered formaldehyde. The sampled fish were processed for histopathological analysis using standard inclusion in wax and staining with the hematoxylin-eosin technique. A control group (control Am) of 100 nonmedicated mollies was included. In group Bm, 300 FZD-treated females received the same dose as above, and were divided into three replicates and stimulated for reproduction with guppy (Poecilia reticulata) at the end of the 12th week. An untreated control group of 100 mollies was also established and induced for reproduction as above (control Bm). Offspring from Bm and control Bm groups were fed a standard commercial diet, FZD-free, and once they reached 1 cm size, 20 fish per replicate were killed and processed as above for histopathological analysis.
In group Cm, 350 FZD-fed mollies were made into fishmeal after 12 weeks of medication with 11 mg of FZD/ kg of feed. This fishmeal was then incorporated into commercial food without withdrawal time at a rate of 500 g of fishmeal/kg of commercial feed. A total of 100 mollies (group Cm 1 ) were fed this ration for 12 weeks. The calculated dose of AOZ was 1.25 mg/kg of mollies biomass, considering a feed consumption of 5% of the biomass weight. At the end of this period, fish were processed as described above, in search of tumors. A nonmedicated control group of 100 mollies (control Cm) was also established.
Tilapia (Oreochromis niloticus)
In all, 325 juvenile male tilapias, sizing 2 cm long, were used in this phase. In group At, 65 fish per replicate and three replicates were included, plus 65 additional fish for the untreated control group (control At). Animals were allocated as already described. Fish received a commercial diet supplemented with FZD at a dose of 50 mg/kg of feed during 60 days. At the end of this period, approximately half of these fish were killed and processed for macroscopic and histopathological analysis, as already described. The other half was made fishmeal and incorporated into a commercial diet at a rate of 500 g/kg of commercial feed. The calculated dose of AOZ was 1.6 mg/kg of tilapia biomass, considering a feed consumption of 5% of the biomass weight. Group Bt of 65 tilapias was fed this FZD residue containing diet for 12 weeks, as a form of medicating AOZ/FOZ. Data from the control At nonmedicated group were also regarded as the control group for group Bt.
Distribution of groups in the two fish species is summarized in Table 1 .
Fishmeal from mollies and tilapias was processed to detect AOZ and FOZ, as described by Conneely et al 16 in triplicates, using an Inertsil separation column ODS (150 Â 4.6 mm ID) and 5 mM oxalic acid-acetonitrile (55 : 45) as mobile phase with UV-vis detection at 265 nm (0.04 a.u.f.s.).
Statistical analysis of data was carried out through the Fisher's nonparametric exact probability test.
RESULTS
The physicochemical variables assessed remained constant in all trials with both species, having the following mean values: temperature 23.6671.21C; pH 6.770.6; ammonium 0.73070.09 mg/l; phosphates 3.070.5 mg/l; nitrates 0.4170.5 mg/l; oxygen 5.670.2 mg/l and water hardness (measured for calcium content) 12076.5 mg/l.
The HPLC analysis revealed the presence of AOZ in the fishmeal prepared with both mollies and tilapias in quantities of 2578.5 and 3274.8 mg/kg, respectively. Only nonquantifiable traces of FOZ were detected in both fishmeal samples. These concentrations of AOZ allowed Carcinogenic effects of furazolidone doses of AOZ equivalent to 1.25 mg/kg of mollies biomass and 1.6 mg/kg of tilapia biomass.
Mollies (Poecilia formosa)
Histopathological studies of mollies revealed a clear indication of liver steatosis in all samples from FZD-treated fish. Control animals did not show such a lesion. From week 3 and until the end of the trial, a clear increase in liver, pancreas, kidney and gonadal melanohistocytomes became apparent in the FZD-treated fish. Figure 1a and b shows some examples of these findings. The weekly rate of renal (a) and/or hepatic (b) melanohistocytoma tumor presentation was as follows: none during the first 2 weeks, then 10, 24, 30, 36, 36, 44, 46, 48, 46 and 44, from the 3rd to the 12th week, respectively. Fisher's exact probability test shows that, when compared with weeks 1 and 2, and with the control group, the FZD-treated group had a statistically significant increment in tumors from week 3 through week 12 (Po0.05). Tumors were not detected in either the control group nor in the mollies fed mollies meal. Also, no tumors were observed in the offspring from surviving mollies medicated with FZD.
Tilapias (Oreochromis niloticus)
No tumors were seen in any of the FZD-treated fish nor in the tilapias fed tilapias meal. In contrast, hepatic steatosis was found in all FZD-treated tilapias. Untreated control fish did not show this lesion.
DISCUSSION
Physicochemical variables assessed in water did not change substantially in any set of trials. It is therefore concluded that it is highly unlikely that the very small fluctuations observed had any impact on observed results. Experimental carcinogenesis using fish species as alternative models has been described as a dynamic, attractive and valuable field of research. 11, 12 Poecilia formosa is a female lineage of live bearing fish that undergo frequent mutations, possess clonal transmission and at least two truly hypervariable loci that substantiate the concept that mollies are prone to mutational alterations both from physical and chemical stimuli. [13] [14] [15] In fact, this fish species has been regarded as more advantageous than the use of rodents to test potential carcinogens. 15 Hence, results in this trial support the use of this fish species for the screening of potentially carcinogenic substances.
A primary goal in this experiment was to compare/ contrast the effects of feeding FZD or AOZ/FOZ in two fish models: one prone to develop tumors (Poecilia formosa), and a second one (Oreochromis niloticus) not distinguished for doing so. Also, in the case of mollies, successive generations were tested to assess a possible accumulation or genomic impact on germinal cells. As expected, evidence gathered in this trail agrees with the established fact that FZD is a carcinogenic substance. 1, 2, 4, 17, 18 In this particular trial, the type of cancer induced by FZD was defined as melanohistiocytoma. These tumors become more apparent and profuse with the time of exposure to FZD. In contrast, none of these tumors were found either in mollies or tilapias fed with AOZ/FOZ-contaminated mollie or tilapia-flour, respectively, nor in the offspring of mollies that survived a 12-week period of treatment with FZD.
The challenge here designed, using the protein-bound metabolites of FZD, was carried out at concentrations of AOZ/FOZ in both fishmeals (from mollies and from tilapias), considerably greater than the reported concentrations of AOZ in swine meat from FZD-medicated animals. 19 This can be explained because of the dehydration process needed to prepare the fishmeal. This methodology differs from simply adding AOZ to the feed, because AOZ from FZD-medicated animals is believed to be covalently linked to tissue proteins, thus resembling the trophic chain in a more accurate way.
An additional goal of this experiment was to evaluate the effects of the food-chain accumulation of FZD metabolites in subsequent generations. No distinguishable effect could be detected in this trial. In fact, the lack of tumorinducing ability of AOZ/FOZ found in these trials, at least for mollies and tilapias, comply better with studies that show lack of mutagenicity of AOZ bound to tissues with or without metabolic activation and using the Salmonella/ microsome test, 20 than with the preconceived assumption that AOZ/FOZ is as potentially toxic to cells as FZD. Klee et al 21 found no acute toxicity of AOZ or digested food residues in gut segments and Caco-2 cells at concentrations that were substantially above the maximum residue levels to be expected in the food of animal origin after administration of therapeutic doses. However, in order to establish with greater certainty whether or not AOZ/FOZ is innocuous to consumers, it will be useful to repeat this trial using larger quantities of purified and protein-linked AOZ and FOZ, as well as to increase the time of exposure to these agents.
Melanohistiocytomes are benign tumors of the melanomacrophage centers. These centers are perfectly encapsulated by the fibrous connective tissue, mainly in the liver and various organs such as the pancreas and kidneys. These cells are known to possess a high cellular division rate; hence their oncogenic liability becomes higher. This appears to be true for Poecilia formosa, a species that required only 3 weeks of exposure to FZD to develop such tumors. Although the combined metabolites AOZ/FOZ endure only minor changes in its chemical structure, they are sufficient to drastically preclude the carcinogenic activity of FZD.
Steatosis was a common finding in all FZD-treated fish, both tilapias and mollies, but this finding was not seen in control groups. The percentage of fat in the food was adequate, that is, 8% for mollies and tilapias. Since control fish did not show steatosis, it is unlikely that the digestibility of the fat source in the commercial feed could be partly responsible for this lesion. 22, 23 In contrast, FZD has been shown to be capable of inducing such changes. It is, however, highly unlikely that steatosis had any relationship with the tumor-inducing properties of FZD or the lack of this effect observed for AOZ/FOZ. In tilapias, neither the relatively large dose of FZD for 90 days, nor the AOZ/FOZ contaminated tilapia meal, induced detectable tumors. These results also suggest that FZD is hardly carcinogenic to food-producing animals when used at therapeutic doses and for a reasonably limited period of time. In fact, a thorough review of literature, assisted through automated data banks, failed to reveal a single reference to a direct FZD tumor-inducing effect in foodproducing species.
Fish dosed with FZD-supplemented food and then used to produce fishmeal to feed other fish appear a sufficient step to deprive FZD of its cancer-inducing properties. This view is in agreement with recent evidence that questions the danger that FZD may pose to human health when used as feed additive in veterinary medicine. 22 These results may be pondered in countries where nitrofurans are still used in animal health, and whose governments still have these agents under examination. However, application of these results to assessing the risks to human consumers was not the object of the study and is the responsibility of regulatory agencies in respective countries.
